ImpactRx, Inc. a Mount Laurel, New Jersey-based provider of intelligence database for tracking the promotional initiatives of the pharmaceutical industry in real time and measuring their effectiveness, has completed a $1.2m Series E financing round.
According to a press relaese, the first tranche of the funding, $678,040, was closed on December 23, 2009.
Commenting on the funding, Richard Altus, CEO and President, was reported as saying: “The additional funding, coupled with the internally generated free cash flow, will help us expedite our product development and infrastructure improvement plans as well as upgrade our modeling capabilities.
“We are investing to accelerate our ability to deliver even more value to our clients”, he said.
Investors in the company include Mediphase Venture Partners, Oxford Bioscience Partners, Merck Capital Ventures, and Omega Funds.